Lakshmikumaran & Sridharan advised LifeCell International, a stem cell bank and reproductive genetic testing services provider, in its recent fundraise of ?2.25 billion (USD 29.8 million) from life sciences investment firm OrbiMed Asia. IndusLaw represented OrbiMed Asia.
Announcing the deal on 22 September, LifeCell International said its existing founders would be investing ?300 million as part of this round.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.
你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章，欢迎成为我们的订阅会员成为我们的订阅会员。
